newsfilter
← Latest News
PR Newswire·

I-Mab to Participate at the Truist Securities BioPharma Symposium

I-Mab (NASDAQ: IMAB), a US-based, global, biotech company, exclusively focused on the development of highly differentiated immunotherapies for the...